Neutrogena ® Rapid Clear ® Stubborn Acne Spot Gel

Manufacturer
Kenvue Brands LLC
Effective date
2026-03-12
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
full-release
Hydrated at
2026-06-01 01:50:30

Label at a glance#

ProductNeutrogena Rapid Clear Stubborn Acne Spot
Active ingredientBENZOYL PEROXIDE
Label structure11 sections

Dosage and administration

Clean the skin thoroughly before applying this product. Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day. If going outside, ap...

Storage and handling

Store at 20°C-25°C (68°F-77°F).

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Benzoyl Peroxide (10%)

Purpose

OTC - PURPOSE SECTION

Acne Medication

Use

INDICATIONS & USAGE SECTION

For the treatment of acne.

Warnings

WARNINGS SECTION

For external use only.

When using this product

OTC - WHEN USING SECTION

  • Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • Avoid unnecessary sun exposure and use a sunscreen.
  • Avoid contact with the eyes, lips and mouth.
  • Avoid contact with hair or dyed fabrics, which may be bleached by this product.
  • Skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.

Do not use if you

OTC - DO NOT USE SECTION

  • Have very sensitive skin.
  • Are sensitive to benzoyl peroxide.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • Irritation becomes severe.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Clean the skin thoroughly before applying this product.
  • Cover the entire affected area with a thin layer one to three times daily.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
  • If going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.

Other Information

STORAGE AND HANDLING SECTION

Store at 20°C-25°C (68°F-77°F).

Inactive Ingredients

INACTIVE INGREDIENT SECTION

water, carbomer homopolymer type B, hydroxypropyl methylcellulose, benzyl alcohol, disodium EDTA, laureth-4, citric acid, sodium hydroxide

Questions?

OTC - QUESTIONS SECTION

Call toll-free 800-582-4048 or 215-273-8755 (collect) or visit www.neutrogena.com

SPL UNCLASSIFIED SECTION

Distributed by:

Kenvue Brands LLC
Summit, NJ 07901

PRINCIPAL DISPLAY PANEL - 28 g Tube in a Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NEUTROGENA ®

Rapid

Clear


Stubborn Acne ®


Spot Gel

MAXIMUM STRENGTH

BENZOYL PEROXIDE

ACNE MEDICINE

reduces size & redness in just 2 hours

NET WT. 1 OZ. (28g)

NeutrogenaNeutrogena

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
486131benzoyl peroxide 10 % Topical GelPSN8
486131benzoyl peroxide 0.1 MG/MG Topical GelSCD8
486131benzoyl peroxide 10 % Topical GelSY8

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130070501024614GTIN-13: 0070501024614
EAN-13: 0070501024614
GTIN-12: 070501024614
UPC-A: 070501024614
GTIN storage (14 digits): 00070501024614
Neutrogena.jpg
Data codeData Matrix30062588Neutrogena.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a46239a7-5963-4008-8cbb-6b9000f497ebProduct name120250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19Product name320250317
d9d61457-6a5a-41fc-b418-e5479a2904b7Product name220230303
32012d5c-25ac-49c7-9d4c-1313177fff7cProduct name120230112
13e7e7e3-e885-4c79-af6d-dad1aedbb06eProduct name120220128
4a7d44fe-774d-404b-aad0-8a90fe78375aProduct name420211025
3f45980c-c196-47e5-0e5e-48b7c57327c5Product name520200428
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27bProduct name320200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992Product name420190619
ad75fcfd-a339-42a1-9c60-43ba2c654cfaProduct name120170810

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69968-0043-1Neutrogena Rapid Clear Stubborn Acne Spot1 in 1 CARTONGEL18
69968-0043-1Neutrogena Rapid Clear Stubborn Acne Spot28 g in 1 TUBEGEL288

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69968-004369968-0043-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Neutrogena Rapid Clear Stubborn Acne SpotBENZOYL PEROXIDEKenvue Brands LLC5b11b2de-d156-4d6a-8024-0a945661cd9a2026-03-12WarningsExact identifier
ndc (package): 69968-0043-1
ndc (product): 69968-0043
ndc11 (package): 69968004301
spl id: 4ccf8cb6-c187-6d28-e063-6394a90ac59e
spl set id: 5b11b2de-d156-4d6a-8024-0a945661cd9a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.